Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI) -- Ignore unavailable to you. Want to Upgrade?

To: Ron who wrote (452)	1/14/1999 2:09:00 PM
From: OldAIMGuy	Respond to of 1154

Hi Ron, GENE has always had good "science" but in years past didn't have the clout to get the "business" end of things done. Yet, as they get these new items out, they should start to get better deals done relative to the science. I own a bunch of shares and last added to my position at $2.50. Even at the rather pathetic price/share it's at today, I'm still profitable overall. Not exactly the level of return that I'd like for owning a stock for 12 years, but at least not a loss. GENE is in my "long term portfolio" and will remain there until I lose patience. The H.Pylori project has been going on for quite some time. If nothing else it will add to GENE's respectibility. As stated, that adds to their negotiating clout and will help long term. Best regards, Tom